The medical technologies advisory committee considered evidence from several sources to determine whether price variation between slide sheets could be justified by differences in their clinical and ...
LSA guidance evaluates categories of technologies that are already in widespread use within the NHS. It assesses whether price variations between technologies in a category are justified by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback